RESALE REGISTRATION RIGHTS AGREEMENT between INDEVUS PHARMACEUTICALS, INC., LEHMAN BROTHERS INC., and WACHOVIA CAPITAL MARKETS, LLC DATED AS OF JULY 16, 2003Resale Registration Rights Agreement • August 13th, 2003 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
RESALE REGISTRATION RIGHTS AGREEMENT, dated as of July 16, 2003, among Indevus Pharmaceuticals, Inc., a Delaware corporation (together with any successor entity, herein referred to as the “Company”), and Lehman Brothers Inc. and Wachovia Capital Markets, LLC (the “Initial Purchasers”).
CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION LICENSE AGREEMENT by and between AVENTIS PHARMA SA and INDEVUS PHARMACEUTICALS, INCLicense Agreement • August 13th, 2003 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT effective as of April 18, 2003 (“Effective Date”), by and between AVENTIS PHARMA SA (“AVENTIS”), a corporation organized and existing under the laws of France and having its principal office at 20 avenue Raymond Aron, 92165 Antony, France (“AVENTIS”) and INDEVUS PHARMACEUTICALS INC., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 99 Hayden Avenue, Suite 200, Lexington, Massachusetts 02421, United States (“INDEVUS”).
